COVID-19 Vaccination-Induced Myopericarditis: An Imager's Perspective
Hilary Bews1, Ashley Bryson2, Tessa Bortoluzzi2
1Section of Cardiology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
COVID-19 vaccine-induced myocarditis is rare. This case series confirms myocarditis in young males after vaccination, showing a generally mild clinical course, with vaccination benefits outweighing risks.
Area of Science:
- Cardiology
- Immunology
- Public Health
Background:
- COVID-19 vaccination is crucial for pandemic control.
- Rare adverse events, such as vaccine-induced myocarditis, require thorough investigation.
Observation:
- A case series of 10 patients diagnosed with COVID-19 vaccine-related myocarditis.
- Patients were predominantly young males (mean age 23 years).
- Symptoms included chest discomfort and elevated cardiac biomarkers, occurring a median of 3 days post-second vaccine dose.
Findings:
- Cardiac magnetic resonance imaging confirmed myocarditis, showing delayed enhancement.
- Systolic function was largely preserved on noninvasive imaging.
- The clinical course was generally benign.
Implications:
- COVID-19 vaccine-induced myocarditis, though rare, is a recognized adverse event.
- The findings support the continued recommendation for COVID-19 vaccination.
- Benefits of vaccination significantly outweigh the identified risks.
More Related Videos
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Pericarditis I: Introduction
Myocarditis I: Introduction
Myocarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
